Inventor · disambiguated record
Neelu Kaila
Also filed as: KAILA NEELU
27 granted patents·16 pending applications·410 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0197US11034694B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 15, 2021·12 cites·22 claims
- 0297US6828344B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·109 cites·16 claims
- 0397US6630496B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Oct 7, 2003·145 cites·18 claims
- 0496US11078201B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Aug 3, 2021·7 cites·22 claims
- 0596US11028085B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 8, 2021·6 cites·22 claims
- 0696US11021481B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 1, 2021·7 cites·22 claims
- 0795US11548890B1HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2021·Granted Jan 10, 2023·3 cites·30 claims
- 0895US9549929B2Pyrrolo[2,3-D]pyrimidine derivativesPFIZER·Filed 2015·Granted Jan 24, 2017·10 cites·29 claims
- 0995US9035074B2Pyrrolo[2,3-D]pyrimidine derivativesPFIZER·Filed 2014·Granted May 19, 2015·20 cites·10 claims
- 1094US6916841B2Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2002·Granted Jul 12, 2005·45 cites·28 claims
- 1193US7432279B24,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the sameWYETH CORP·Filed 2006·Granted Oct 7, 2008·35 cites·31 claims
- 1286US11926625B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 12, 2024·1 cites·17 claims
- 1385US9545405B2Pyrrolo[2,3-D]pyrimidine derivativesPFIZER·Filed 2015·Granted Jan 17, 2017·2 cites·18 claims
- 1483US9670201B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2015·Granted Jun 6, 2017·3 cites·14 claims
- 1583US2024025898A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2023·Application pending·0 cites
- 1682US10426135B2Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2019·Granted Oct 1, 2019·2 cites·7 claims
- 1777US10227346B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therofPFIZER·Filed 2018·Granted Mar 12, 2019·1 cites·4 claims
- 1875US12466841B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2023·Granted Nov 11, 2025·0 cites·24 claims
- 1972US12215105B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2020·Granted Feb 4, 2025·0 cites·18 claims
- 2072US2024199603A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2024·Application pending·0 cites
- 2170US10385036B2Sulfonamide-substituted indole modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Aug 20, 2019·1 cites·13 claims
- 2268US10336748B2Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Jul 2, 2019·1 cites·11 claims
- 2367US2020039960A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 2466US12071442B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2022·Granted Aug 27, 2024·0 cites·19 claims
- 2565US2019144429A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 2665US2019387710A1Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use ThereofPFIZER·Filed 2019·Application pending·0 cites
- 2763US2016046597A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2014·Application pending·0 cites
- 2863US2018282304A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2018·Application pending·0 cites
- 2962US2018086736A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 3060US2025011331A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Application pending·0 cites
- 3160US2017233371A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 3255US12252488B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 18, 2025·0 cites·22 claims
- 3352US2025270200A1Ctps1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2023·Application pending·0 cites
- 3450US2009076077A1Methods and Compositions for Selectin InhibitionWYETH CORP·Filed 2008·Application pending·0 cites
- 3548US7994333B2Methods and compositions for selectin inhibitionWYETH LLC·Filed 2008·Granted Aug 9, 2011·0 cites·6 claims
- 3646US12331046B2CTPS1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2021·Granted Jun 17, 2025·0 cites·10 claims
- 3746US7465799B2Methods and compositions for selectin inhibitionWYETH CORP·Filed 2004·Granted Dec 16, 2008·0 cites·16 claims
- 3845US7465798B2Methods and compositions for selectin inhibitionWYETH CORP·Filed 2004·Granted Dec 16, 2008·0 cites·35 claims
- 3940US2008242700A1Methods and Compositions for Selectin InhibitionWYETH CORP·Filed 2008·Application pending·0 cites
- 4039US2006264460A13-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the sameWYETH CORP·Filed 2006·Application pending·0 cites
- 4138US2008255192A1Methods and Compositions for Selectin InhibitionWYETH CORP·Filed 2008·Application pending·0 cites
- 4232US10966980B2Pyrrolo[2,3-d]pyrimidine derivativesPFIZER·Filed 2015·Granted Apr 6, 2021·0 cites·2 claims
- 4332US2011105509A1Indole based receptor crth2 antagonistsWYETH LLC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →